News

Published on 7 Oct 2023 on Simply Wall St. via Yahoo Finance

Swelling losses haven't held back gains for Veracyte (NASDAQ:VCYT) shareholders since they're up...


Article preview image

Veracyte, Inc. (NASDAQ:VCYT) shareholders have seen the share price descend 17% over the month. But that doesn't change the fact that shareholders have received really good returns over the last five years. In fact, the share price is 112% higher today. We think it's more important to dwell on the long term returns than the short term returns. Ultimately business performance will determine whether the stock price continues the positive long term trend. While the returns over the last 5 years have been good, we do feel sorry for those shareholders who haven't held shares that long, because the share price is down 48% in the last three years.

Since the long term performance has been good but there's been a recent pullback of 3.5%, let's check if the fundamentals match the share price.

View our latest analysis for Veracyte

NASDAQ.VCYT price evolution
NASDAQ.AWRE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
What Makes Veracyte (VCYT) a Lucrative Investment?

Next Century Growth Investors, LLC, an investment Management Company, released its “Micro-Cap Str...

Insider Monkey via Yahoo Finance 2 Apr 2024

Veracyte's (VCYT) Q4 Loss Widens, Gross Margin Expands

Veracyte VCYT delivered a diluted loss of 39 cents per share in the fourth quarter of 2023 compar...

Zacks via Yahoo Finance 23 Feb 2024

Veracyte, Inc. (NASDAQ:VCYT) Q4 2023 Earnings Call Transcript

Veracyte, Inc. (NASDAQ:VCYT) Q4 2023 Earnings Call Transcript February 22, 2024 Veracyte, Inc. mi...

Insider Monkey via Yahoo Finance 23 Feb 2024

Swelling losses haven't held back gains for Veracyte (NASDAQ:VCYT) shareholders since they're up...

Veracyte, Inc. (NASDAQ:VCYT) shareholders have seen the share price descend 17% over the month. B...

Simply Wall St. via Yahoo Finance 7 Oct 2023

Veracyte (VCYT) Reports Q2 Loss, Tops Revenue Estimates

Veracyte (VCYT) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Esti...

Zacks via Yahoo Finance 8 Aug 2023

Veracyte, Inc.'s (NASDAQ:VCYT) Revenues Are Not Doing Enough For Some Investors

With a price-to-sales (or "P/S") ratio of 6x Veracyte, Inc. (NASDAQ:VCYT) may be sending very bul...

Simply Wall St. via Yahoo Finance 30 May 2023

Veracyte (VCYT) Reports Q1 Loss, Tops Revenue Estimates

Veracyte (VCYT) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Esti...

Zacks via Yahoo Finance 4 May 2023

The five-year returns have been strong for Veracyte (NASDAQ:VCYT) shareholders despite underlying...

It hasn't been the best quarter for Veracyte, Inc. (NASDAQ:VCYT) shareholders, since the share pr...

Simply Wall St. via Yahoo Finance 18 Apr 2023

Estimating The Intrinsic Value Of Veracyte, Inc. (NASDAQ:VCYT)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Veracyte fair value estimate is US$20.37...

Simply Wall St. via Yahoo Finance 23 Mar 2023

Best Momentum Stocks to Buy for January 24th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider...

Zacks via Yahoo Finance 24 Jan 2023